De Chao Yu
Fortune : 1 170 M $ au 31/05/2026
Fortune : 1 170 M $ au 31/05/2026
Fondateur d'Innovent Biologics, Inc. et de Chengdu Kanghong Pharmaceutical Group Co., Ltd, De Chao Yu occupe le poste de président-directeur général d'Innovent Biologics, Inc. et de président de la Chinese Antibody Society. Il est également membre du conseil d'administration du Babytree Group et du Cheerwin Group Ltd. et professeur à l'université du Sichuan. De Chao Yu était auparavant président et directeur général de Chengdu Kanghong Pharmaceutical Group Co. Ltd, vice-président de la recherche et du développement d'Applied Genetic Technologies Corp, vice-président de la recherche et du développement d'Applied Genetics, Inc, président et directeur général de Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd, vice-président chargé de la recherche et du développement chez Calyon North America, Inc. et vice-président chez Calydon, Inc. et directeur général de la China Medicinal Biotech Association. Il a reçu un doctorat de l'Académie chinoise des sciences.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INNOVENT BIOLOGICS, INC. 6,33 % | 11/05/2026 | 110 058 657 ( 6,33 % ) | 1 170 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INNOVENT BIOLOGICS, INC. | Directeur Général | 28/04/2011 |
| DIAN DIAGNOSTICS GROUP CO.,LTD. | Directeur/Membre du Conseil | 03/11/2023 |
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2008 |
Chinese Antibody Society
Chinese Antibody Society Miscellaneous Commercial ServicesCommercial Services Engages in therapeutic antibodies services | Président | 01/01/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
| BABYTREE GROUP | Directeur/Membre du Conseil | 10/05/2023 |
| CHEERWIN GROUP LIMITED | Directeur/Membre du Conseil | 14/10/2022 |
China Medicinal Biotech Association | Corporate Officer/Principal | 01/01/2019 |
| PHARMABLOCK SCIENCES (NANJING), INC. | Directeur/Membre du Conseil | 01/01/2018 |
| CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD | Directeur Général | 01/01/2011 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 15 |
|---|---|
Calydon, Inc.
Calydon, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products for cancer | Health Technology |
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calyon North America, Inc.
Calyon North America, Inc. Regional BanksFinance Part of SAS Rue la Boétie, Calyon North America, Inc. is a company based in New York, NY. | Finance |
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells traditional Chinese and biologic drugs | Health Technology |
China Medicinal Biotech Association | |
Dian Diagnostics Group Co. Ltd.
Dian Diagnostics Group Co. Ltd. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Health Services |
Innovent Biologics, Inc.
Innovent Biologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Applied Genetics, Inc.
Applied Genetics, Inc. Applied Genetics Laboratories, Inc. is a company that specializes in cytogenetic analysis and genomic research for the medical and pharmaceutical industries. The company offers state-of-the-art cytogenetics analysis services, including karyotyping and fluorescence in situ hybridization (Fish) studies, that are tailored to meet the unique needs of their clients while ensuring compliance with FDA Good Laboratory Practice regulations. The company also provides Hybloc™ DNA and normal human metaphase slides for genomic research, contributing to groundbreaking research in medicine, vaccine production, and tissue engineering. The company has been delivering GLP-compliant cytogenomic characterization and species verification for over 30 years and is led by a team of industry experts. The company is based in Brookings, SD. | |
Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd.
Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
PharmaBlock Sciences (Nanjing), Inc.
PharmaBlock Sciences (Nanjing), Inc. Miscellaneous Commercial ServicesCommercial Services Provides technical services related to the research and development of drug molecular building blocks and process production | Commercial Services |
Babytree Group
Babytree Group Advertising/Marketing ServicesCommercial Services Provides advertising and e-Commerce services | Commercial Services |
Chinese Antibody Society
Chinese Antibody Society Miscellaneous Commercial ServicesCommercial Services Engages in therapeutic antibodies services | Commercial Services |
Cheerwin Group Ltd.
Cheerwin Group Ltd. Chemicals: AgriculturalProcess Industries Develops, manufactures and sells online household & personal care and pet products | Process Industries |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national